Funding from the European Union
KI is the second largest recipient of EU funding in Sweden and for KI, the EU is the most important international research financier. In total, the EU contributed approximately SEK 265 million to KI's research in 2017.
Project funding from EU
During 2017, KI participated in 200 EU funded research projects, of which 12 were coordinated from KI. Within the EU Health Programs, KI has about 70 active projects, and our researchers also participate in projects within the infrastructure, information and communication technology, nanoscience and environment programs. KI also took part in 14 projects within the EU Commission and the pharmaceutical industry's joint venture Innovative Medicines Initiative (IMI) during the year.
|EU projects at KI 2010-2017|
|Total number of projects||204||222||234||229||202||214||198||200|
|– with KI as coordinator||29||31||21||19||15||12||11||12|
European funding to individual researchers at KI mainly comes from the European Research Council (ERC) or the Research Executive Agency (REA). In 2017, nine new projects started with support from ERC. By the end of 2017 there were 37 active ERC projects at KI, of which 33 were led by KI researchers.
Individual Marie Curie Grants
Marie Curie is the collective name for the EU Commission's programme addressed to research career development. There are two main types of Marie Curie Programmes, individual fellowships and network grants. Karolinska Institutet has in recent years been quite successful in the competition for individual Marie Curie fellowships.
EIT Health is a new innovation initiative focusing on healthy living and active aging. EIT Health is co-funded by the European Institute of Innovation and Technology, EIT, which in turn is an EU-funded initiative to stimulate collaboration between academic research and industry. KI is one of the players in this major European research consortium concentrated in seven centers, or so-called nodes, in Europe. The goal with EIT Health is to contribute to increasing the competitiveness of European industry, improve the quality of life of Europe’s citizens and the sustainability of healthcare system.